Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helge Bruns

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Annals of Transplantation|October 16, 2013
Sulforaphane protects hearts from early injury after experimental transplantationZhanqing Li, Uwe Galli, Luis E Becker, et al.
Clinical Transplantation|May 19, 2011
LabMELD-based organ allocation increases total costs of liver transplantation: a single-center experienceHelge Bruns, Norbert Hillebrand, Tobias Schneider, et al.
Tissue Engineering|January 18, 2006
Injectable liver: a novel approach using fibrin gel as a matrix for culture and intrahepatic transplantation of hepatocytesHelge Bruns, Ulrich Kneser, Stephanie Holzhüter, et al.
Journal of Cellular and Molecular Medicine|November 21, 2007
Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratoryHenning C Fiegel, Peter M Kaufmann, Helge Bruns, et al.
Amino Acids|January 7, 2014
Glycine inhibits angiogenic signaling in human hepatocellular carcinoma cellsHelge Bruns, Marius Petrulionis, Daniel Schultze, et al.
Amino Acids|September 21, 2010
Dietary glycine protects from chemotherapy-induced hepatotoxicitySaulius Mikalauskas, Laura Mikalauskiene, Helge Bruns, et al.
Annals of Transplantation|September 20, 2013
Sulforaphane decreases kidney injury after transplantation in rats: role of mitochondrial damageAlbertas Cekauskas, Helge Bruns, Martynas Manikas, et al.
Langenbeck'S Archives of Surgery|November 1, 2012
HTK-N, a modified HTK solution, decreases preservation injury in a model of microsteatotic rat liver transplantationQinlong Liu, Helge Bruns, Daniel Schultze, et al.
Oncology Reports|September 30, 2022
Sulforaphane has an additive anticancer effect to FOLFOX in highly metastatic human colon carcinoma cellsAgnė Čižauskaitė, Dainius Šimčikas, Daniel Schultze, et al.
Annals of Transplantation|November 2, 2016
Impact of Inter-Laboratory Variability on Model of End-Stage Liver Disease (MELD) Score CalculationMohammed Al-Saeedi, Taha Yassein, Daniel Schultze, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Annals of Transplantation|October 16, 2013
Sulforaphane protects hearts from early injury after experimental transplantationZhanqing Li, Uwe Galli, Luis E Becker, et al.
Clinical Transplantation|May 19, 2011
LabMELD-based organ allocation increases total costs of liver transplantation: a single-center experienceHelge Bruns, Norbert Hillebrand, Tobias Schneider, et al.
Tissue Engineering|January 18, 2006
Injectable liver: a novel approach using fibrin gel as a matrix for culture and intrahepatic transplantation of hepatocytesHelge Bruns, Ulrich Kneser, Stephanie Holzhüter, et al.
Journal of Cellular and Molecular Medicine|November 21, 2007
Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratoryHenning C Fiegel, Peter M Kaufmann, Helge Bruns, et al.
Amino Acids|January 7, 2014
Glycine inhibits angiogenic signaling in human hepatocellular carcinoma cellsHelge Bruns, Marius Petrulionis, Daniel Schultze, et al.
Amino Acids|September 21, 2010
Dietary glycine protects from chemotherapy-induced hepatotoxicitySaulius Mikalauskas, Laura Mikalauskiene, Helge Bruns, et al.
Annals of Transplantation|September 20, 2013
Sulforaphane decreases kidney injury after transplantation in rats: role of mitochondrial damageAlbertas Cekauskas, Helge Bruns, Martynas Manikas, et al.
Langenbeck'S Archives of Surgery|November 1, 2012
HTK-N, a modified HTK solution, decreases preservation injury in a model of microsteatotic rat liver transplantationQinlong Liu, Helge Bruns, Daniel Schultze, et al.
Oncology Reports|September 30, 2022
Sulforaphane has an additive anticancer effect to FOLFOX in highly metastatic human colon carcinoma cellsAgnė Čižauskaitė, Dainius Šimčikas, Daniel Schultze, et al.
Annals of Transplantation|November 2, 2016
Impact of Inter-Laboratory Variability on Model of End-Stage Liver Disease (MELD) Score CalculationMohammed Al-Saeedi, Taha Yassein, Daniel Schultze, et al.
Pageof 4